Summary

Endocrine disruptors (EDs) are defined as exogenous chemicals that alter functions of the endocrine system, thereby causing adverse health effects in an organism or its progeny. The project brings together experts in various research fields, including systems toxicologists, experimental biologists with a thorough understanding of the molecular mechanisms of metabolic disease and comprehensive in vitro and in vivo methodological skills and ultimately, epidemiologists linking environmental exposure to adverse metabolic outcomes. This proposal focuses on developing novel test methods and models to assess the metabolic effects of EDs. Combined in silico methods, in vitro and in vivo methods are developed with an emphasis on liver and adipose tissue and endocrine pathways related to their metabolism. In addition, epidemiological and field monitoring data is used to gain information regarding the exposure to chemicals and ED-related metabolic effects. The interdisciplinary approach and complementary expertise of the participants will identify novel mechanisms of action and provide an interface for regulatory purposes.

Funded by the European Union (Horizon 2020) under Grant agreement ID 825762
Participants: OULUN YLIOPISTO – Finland | EUROSAFE – France | PAMGENE INTERNATIONAL BV – Netherlands | EBERHARD KARLS UNIVERSITAET TUEBINGEN – Germany | UNIVERZITA KARLOVA – Czechia | WAGENINGEN UNIVERSITY – Netherlands | UNIVERSITY OF LEEDS – United Kingdom | CSIC – Spain | BUNDESINSTITUT FUER RISIKOBEWERTUNG – Germany | NORGES TEKNISK-NATURVITENSKAPELIGE UNIVERSITET NTNU – Norway

Principal Investigators

Staff